1. Home
  2. KE vs NMRA Comparison

KE vs NMRA Comparison

Compare KE & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$26.25

Market Cap

617.2M

Sector

Technology

ML Signal

HOLD

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

554.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
NMRA
Founded
1961
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
617.2M
554.0M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
KE
NMRA
Price
$26.25
$2.02
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$28.00
$6.57
AVG Volume (30 Days)
108.9K
1.1M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.23
EPS
0.55
N/A
Revenue
$1,486,727,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$47.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.85
$0.63
52 Week High
$33.19
$3.65

Technical Indicators

Market Signals
Indicator
KE
NMRA
Relative Strength Index (RSI) 61.88 33.77
Support Level $26.23 $1.79
Resistance Level $27.02 $2.20
Average True Range (ATR) 0.88 0.16
MACD 0.34 -0.01
Stochastic Oscillator 87.74 22.64

Price Performance

Historical Comparison
KE
NMRA

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: